PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2017YFC0908003, 2017YFC0908004, 18ZXDBSY00020)
  • Tianjin Medical University (2017ZDSYS12)

This publication has 22 references indexed in Scilit: